Full Name: BRCA1 and BRCA2 Comprehensive Genetic Analysis
🧪 Genetic Test | Full Gene Sequencing + Deletion/Duplication Analysis

Overview:
Evaluates inherited mutations in BRCA1 and BRCA2 associated with increased risk for breast, ovarian, prostate, and other cancers. Used for cancer risk assessment and management planning.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 10–21 business days

Full Name: C-Peptide, Serum
🧪 Single Test | 1 Biomarker

Overview:
Measures endogenous insulin production. Useful in distinguishing type 1 vs type 2 diabetes and evaluating insulin resistance or hypoglycemia.

Fasting: 8–10 hours recommended
Timing: Morning draw preferred
Turnaround Time: 2–4 business days

Full Name: C-Reactive Protein (CRP)
🧪 Single Test | 1 Inflammatory Marker

Overview:
Detects acute inflammation or infection. Used for general inflammatory assessment and disease activity monitoring.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 1–2 business days

Full Name: Cancer Antigen 125 (CA-125)
🧪 Single Test | 1 Tumor Marker

Overview:
Used to monitor ovarian cancer treatment and recurrence. Levels may also be elevated in benign gynecologic or inflammatory conditions.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 2–4 business days

Full Name: Cancer Antigen 15-3 (CA 15-3)
🧪 Single Test | 1 Tumor Marker

Overview:
Primarily used to monitor treatment response and recurrence in patients with breast cancer. Not intended for cancer screening in asymptomatic individuals.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 2–4 business days

Full Name: Cancer Antigen 19-9 (CA 19-9)
🧪 Single Test | 1 Tumor Marker

Overview:
Used in monitoring pancreatic cancer and certain gastrointestinal malignancies. Levels may also be elevated in benign hepatobiliary conditions.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 2–4 business days

Full Name: Cancer Antigen 27-29 (CA 27-29)
🧪 Single Test | 1 Tumor Marker

Overview:
Used for ongoing monitoring of breast cancer activity and response to therapy. Complements CA 15-3 in select clinical scenarios.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 2–4 business days

Full Name: Carbamazepine, Total Serum Level
🧪 Single Test | Therapeutic Drug Level

Overview:
Measures carbamazepine concentration to ensure therapeutic dosing and prevent toxicity. Used in seizure disorders, bipolar disorder, and neuropathic pain management.

Fasting: Not required
Timing: Trough level preferred (just before next dose)
Turnaround Time: 1–2 business days

Full Name: Complete Blood Count with Automated Differential and Platelet Count
🧪 Grouped Test | ~20–25 Hematologic Markers

Overview:
Evaluates red blood cells, white blood cells, and platelets. Used to assess anemia, infection, inflammation, bleeding risk, and overall bone marrow function.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 1–3 business days

Full Name: Carcinoembryonic Antigen
🧪 Single Test | 1 Tumor Marker

Overview:
Used primarily to monitor colorectal cancer treatment and recurrence. May also be elevated in smokers and benign inflammatory conditions.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 2–4 business days

Full Name: Ceruloplasmin, Serum
🧪 Single Test | 1 Biomarker

Overview:
Evaluates copper transport and metabolism. Commonly used in the assessment of Wilson disease and other liver or neurologic disorders.

Fasting: Not required
Timing: Any time of day
Turnaround Time: 2–4 business days

Full Name: Chlamydia trachomatis Nucleic Acid Amplification Test (Urine)
🧪 Single Test | Molecular Detection

Overview:
Highly sensitive screening test for Chlamydia trachomatis infection. Recommended for sexually active individuals and routine STI screening.

Fasting: Not required
Timing: First-catch urine preferred
Turnaround Time: 1–3 business days